Skip to content

A Study of Repetitive Transcranial Magnetic Stimulation in Bipolar Patients

Repetitive Transcranial Magnetic Stimulation (rTMS) to Improve Cognitive Function and Prevent Relapses in Bipolar Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03207048
Enrollment
42
Registered
2017-07-02
Start date
2017-07-10
Completion date
2019-12-30
Last updated
2020-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder, Cognitive Impairment, Relapse

Brief summary

This study will investigate the effect of Repetitive transcranial magnetic stimulation (rTMS) on cognition and long-term clinical outcomes of bipolar patients.

Detailed description

Cognitive deficits are core features of bipolar disorder. Preliminary evidence shows that repetitive transcranial magnetic stimulation (rTMS) might have positive effects in enhancing cognition and improving clinical symptoms in patients with depression. This study will investigate the effect of rTMS on cognition and long-term outcomes (12 month) of bipolar patients.

Interventions

DEVICERepetitive Transcranial Magnetic Stimulation

Daily left DLPFC, at 110% motor threshold, with a frequency of 10 Hz. Stimulation will be applied in 3-second trains with a 15-second inter-train interval, for 50 trains per session

DEVICESham repetitive transcranial magnetic stimulation

Sham Transcranial Magnetic Stimulation

Sponsors

Guangzhou Psychiatric Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Bipolar Type I or II subjects diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) * Age 18-60 years * Rating on 24-items Hamilton Depression Rating Scale (HAMD)\<18 * Rating on the Young Mania Rating Scale (YMRS) \< 12

Exclusion criteria

* History of any DSM-IV Axis I diagnosis other than BD Type I or II * Implanted medication pump or cardiac pacemaker; * Have had prior brain surgery * Any metal in the head (except in mouth) * Any disease of increased Intracranial pressure * Suicide attempt * Pharmacotherapy * unstable medical conditions * in the process of changing and redrawing withdrawing psychoactive medications within the past 4 weeks (except for sleeping medications such as benzodiazepines)

Design outcomes

Primary

MeasureTime frameDescription
Changes in the MATRICS Consensus Cognitive Batteryone weeks after the completion of the rTMS treatment)Changes in neurocognitive and social function (measured by the The MATRICS Consensus Cognitive Battery) after 2 session of rTMS treatments (20 times)

Secondary

MeasureTime frameDescription
relapses of depressive and/or hypo/mania episode12 monthsThe number of patients who have depression and/or hyop/mania episodes over period of 12 months.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026